BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1261 related articles for article (PubMed ID: 30477559)

  • 1. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
    Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-coded miR-BART13 promotes nasopharyngeal carcinoma cell growth and metastasis via targeting of the NKIRAS2/NF-κB pathway.
    Xu YJ; Zhou R; Zong JF; Lin WS; Tong S; Guo QJ; Lin C; Lin SJ; Chen YX; Chen MR; Chen HL; Ye YB; Pan JJ
    Cancer Lett; 2019 Apr; 447():33-40. PubMed ID: 30684592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus (EBV) encoded microRNA BART8-3p drives radioresistance-associated metastasis in nasopharyngeal carcinoma.
    Zhou X; Lin Y; Chen Y; Wang L; Peng X; Liao J; Zeng H; Luo W; Wu D; Cai L
    J Cell Physiol; 2021 Sep; 236(9):6457-6471. PubMed ID: 33694159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBV encoded miRNA BART8-3p promotes radioresistance in nasopharyngeal carcinoma by regulating ATM/ATR signaling pathway.
    Zhou X; Zheng J; Tang Y; Lin Y; Wang L; Li Y; Liu C; Wu D; Cai L
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31471531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN.
    Cai LM; Lyu XM; Luo WR; Cui XF; Ye YF; Yuan CC; Peng QX; Wu DH; Liu TF; Wang E; Marincola FM; Yao KT; Fang WY; Cai HB; Li X
    Oncogene; 2015 Apr; 34(17):2156-66. PubMed ID: 25347742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBV-miR-BART10-3p facilitates epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma by targeting BTRC.
    Yan Q; Zeng Z; Gong Z; Zhang W; Li X; He B; Song Y; Li Q; Zeng Y; Liao Q; Chen P; Shi L; Fan S; Xiang B; Ma J; Zhou M; Li X; Yang J; Xiong W; Li G
    Oncotarget; 2015 Dec; 6(39):41766-82. PubMed ID: 26497204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of ABI2 expression by EBV-miR-BART13-3p induces epithelial-mesenchymal transition of nasopharyngeal carcinoma cells through upregulation of c-JUN/SLUG signaling.
    Huang J; Qin Y; Yang C; Wan C; Dai X; Sun Y; Meng J; Lu Y; Li Y; Zhang Z; Wu B; Xu S; Jin H; Yang K
    Aging (Albany NY); 2020 Jan; 12(1):340-358. PubMed ID: 31907338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma Epstein-Barr virus microRNA BART8-3p as a potential biomarker for detection and prognostic prediction in early nasopharyngeal carcinoma.
    Lin C; Chen Y; Lin X; Peng H; Huang J; Lin S; Pan J; Li M; Zong J
    Sci Rep; 2024 Mar; 14(1):7433. PubMed ID: 38548853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma Epstein-Barr Virus MicroRNA BART8-3p as a Diagnostic and Prognostic Biomarker in Nasopharyngeal Carcinoma.
    Lin C; Lin K; Zhang B; Su Y; Guo Q; Lu T; Xu Y; Lin S; Zong J; Pan J
    Oncologist; 2022 Apr; 27(4):e340-e349. PubMed ID: 35380720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma.
    Lung RW; Hau PM; Yu KH; Yip KY; Tong JH; Chak WP; Chan AW; Lam KH; Lo AK; Tin EK; Chau SL; Pang JC; Kwan JS; Busson P; Young LS; Yap LF; Tsao SW; To KF; Lo KW
    J Pathol; 2018 Apr; 244(4):394-407. PubMed ID: 29230817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell metastasis and invasion by targeting long non-coding RNA LOC553103.
    He B; Li W; Wu Y; Wei F; Gong Z; Bo H; Wang Y; Li X; Xiang B; Guo C; Liao Q; Chen P; Zu X; Zhou M; Ma J; Li X; Li Y; Li G; Xiong W; Zeng Z
    Cell Death Dis; 2016 Sep; 7(9):e2353. PubMed ID: 27584792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis.
    Wang D; Zeng Z; Zhang S; Xiong F; He B; Wu Y; Li W; Tang L; Wei F; Xiang B; Li Z; Zhou Y; Zhou M; Li X; Li Y; Li G; Xiong W; Guo C
    FASEB J; 2020 Jun; 34(6):8012-8027. PubMed ID: 32306460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus-encoded microRNA BART22 serves as novel biomarkers and drives malignant transformation of nasopharyngeal carcinoma.
    Zhang T; Chen Z; Deng J; Xu K; Che D; Lin J; Jiang P; Gu X; Xu B
    Cell Death Dis; 2022 Jul; 13(7):664. PubMed ID: 35907914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction to: EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
    Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
    J Exp Clin Cancer Res; 2019 Jan; 38(1):34. PubMed ID: 30678708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.
    Zheng X; Wang J; Wei L; Peng Q; Gao Y; Fu Y; Lu Y; Qin Z; Zhang X; Lu J; Ou C; Li Z; Zhang X; Liu P; Xiong W; Li G; Yan Q; Ma J
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of EB virus miR-BART4 inhibits proliferation and aggressiveness while promoting radiosensitivity of nasopharyngeal carcinoma.
    Wu Q; Han T; Sheng X; Zhang N; Wang P
    Biomed Pharmacother; 2018 Dec; 108():741-751. PubMed ID: 30248542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Epstein-Barr virus microRNAs miR-BART7 and miR-BART13 as biomarkers for nasopharyngeal carcinoma diagnosis and treatment.
    Zhang G; Zong J; Lin S; Verhoeven RJ; Tong S; Chen Y; Ji M; Cheng W; Tsao SW; Lung M; Pan J; Chen H
    Int J Cancer; 2015 Mar; 136(5):E301-12. PubMed ID: 25213622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma.
    Cai L; Li J; Zhang X; Lu Y; Wang J; Lyu X; Chen Y; Liu J; Cai H; Wang Y; Li X
    Oncotarget; 2015 Apr; 6(10):7838-50. PubMed ID: 25691053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-encoded microRNA BART1 induces tumour metastasis by regulating PTEN-dependent pathways in nasopharyngeal carcinoma.
    Cai L; Ye Y; Jiang Q; Chen Y; Lyu X; Li J; Wang S; Liu T; Cai H; Yao K; Li JL; Li X
    Nat Commun; 2015 Jul; 6():7353. PubMed ID: 26135619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.